Late-stage Disease at Presentation to an HIV Clinic in Eastern Tanzania: A Retrospective Cross-sectional Study

Overview

Journal Malawi Med J

Specialty General Medicine

Date 2016 Mar 9

PMID 26952140

Citations 11

Authors

H Mhozya

D Bintabara

S Kibusi

E Neilson

B C Mpondo

Affiliations

Soon will be listed here.

Abstract

Background: Late presentation and delayed treatment initiation is associated with poor outcomes in patients with HIV. Little is known about the stage at which HIV patients present at HIV clinics in Tanzania.

Aim: This study aimed at determining the proportion of HIV patients presenting with WHO clinical stages 3 and 4 disease, and the level of immunity at the time of enrollment at the care and treatment center.

Methods: A retrospective cross-sectional study was conducted among 366 HIV-infected adults attending HIV clinic at Mwananyamala Hospital in Dar es Salaam, Tanzania. Data were obtained from the care and treatment clinic database.

Results: Late stage disease at the time of presentation was found in 276 (75.4%) of the patients; out of whom 153 (41.8%) presented with CD4 count <200 cells/ul and 229 (62.6%) presented with WHO clinical stage 3 or 4 at the time of clinic enrollment. Strategies to improve early diagnosis and treatment initiation should be improved.

Citing Articles

Prevalence, Predictors, and Outcomes of HIV Care in HIV-Positive Clients Entering HIV Care With Advanced HIV Disease in Sub-Saharan Africa 2010-2022: Systematic Review and Meta-Analysis.

Haumba S, Arora S, Williams V, Maseko T, Mafukidze A, Ojoo S Health Sci Rep. 2024; 7(12):e70285.

PMID: 39720238 PMC: 11667100. DOI: 10.1002/hsr2.70285.

Persistent High Burden and Mortality Associated With Advanced HIV Disease in Rural Tanzania Despite Uptake of World Health Organization "Test and Treat" Guidelines.

Stoger L, Katende A, Mapesi H, Kalinjuma A, van Essen L, Klimkait T Open Forum Infect Dis. 2022; 9(12):ofac611.

PMID: 36540386 PMC: 9757676. DOI: 10.1093/ofid/ofac611.

Advanced baseline immunosuppression is associated with elevated levels of plasma markers of fungal translocation and inflammation in long-term treated HIV-infected Tanzanians.

Barabona G, Mahiti M, Toyoda M, Kamori D, Masoud S, Judicate G AIDS Res Ther. 2021; 18(1):55.

PMID: 34446039 PMC: 8394626. DOI: 10.1186/s12981-021-00381-9.

Adrenal Insufficiency: A Forgotten Diagnosis in HIV/AIDS Patients in Developing Countries.

Nassoro D, Mkhoi M, Sabi I, Meremo A, Lawala P, Mwakyula I Int J Endocrinol. 2019; 2019:2342857.

PMID: 31341472 PMC: 6612386. DOI: 10.1155/2019/2342857.

Magnitude and correlates of virological failure among adult HIV patients receiving PI based second line ART regimens in north western Tanzania; a case control study.

Gunda D, Kilonzo S, Mtaki T, Bernard D, Kalluvya S, Shao E BMC Infect Dis. 2019; 19(1):235.

PMID: 30845924 PMC: 6407235. DOI: 10.1186/s12879-019-3852-3.

References

Krentz H, Auld M, Gill M . The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection. HIV Med. 2004; 5(2):93-8. DOI: 10.1111/j.1468-1293.2004.00193.x. View

Braitstein P, Brinkhof M, Dabis F, Schechter M, Boulle A, Miotti P . Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006; 367(9513):817-24. DOI: 10.1016/S0140-6736(06)68337-2. View

Girardi E, Sabin C, Monforte A . Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr. 2007; 46 Suppl 1:S3-8. DOI: 10.1097/01.qai.0000286597.57066.2b. View

Huruy K, Mulu A, Mengistu G, Shewa-Amare A, Akalu A, Kassu A . Immune reconstitution inflammatory syndrome among HIV/AIDS patients during highly active antiretroviral therapy in Addis Ababa, Ethiopia. Jpn J Infect Dis. 2008; 61(3):205-9. View

Lima V, Johnston K, Hogg R, Levy A, Harrigan P, Anema A . Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis. 2008; 198(1):59-67. DOI: 10.1086/588673. View

Kelley C, Kitchen C, Hunt P, Rodriguez B, Hecht F, Kitahata M . Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis. 2009; 48(6):787-94. PMC: 2720023. DOI: 10.1086/597093. View

Kigozi I, Dobkin L, Martin J, Geng E, Muyindike W, Emenyonu N . Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009; 52(2):280-9. PMC: 2815238. DOI: 10.1097/QAI.0b013e3181ab6eab. View

Byamugisha R, Tylleskar T, Kagawa M, Onyango S, Karamagi C, Tumwine J . Dramatic and sustained increase in HIV-testing rates among antenatal attendees in Eastern Uganda after a policy change from voluntary counselling and testing to routine counselling and testing for HIV: a retrospective analysis of hospital records,.... BMC Health Serv Res. 2010; 10:290. PMC: 2964695. DOI: 10.1186/1472-6963-10-290. View

Hoffman S, Wu Y, Lahuerta M, Kulkarni S, Nuwagaba-Biribonwoha H, El Sadr W . Advanced disease at enrollment in HIV care in four sub-Saharan African countries: change from 2006 to 2011 and multilevel predictors in 2011. AIDS. 2014; 28(16):2429-38. PMC: 4361092. DOI: 10.1097/QAD.0000000000000427. View

10.

Wajanga B, Webster L, Peck R, Downs J, Mate K, Smart L . Inpatient mortality of HIV-infected adults in sub-Saharan Africa and possible interventions: a mixed methods review. BMC Health Serv Res. 2014; 14:627. PMC: 4265398. DOI: 10.1186/s12913-014-0627-9. View